Javascript must be enabled to continue!
Long-Term Functional and Quality-of-Life Outcomes in Survivors of Refractory Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation
View through CrossRef
IMPORTANCE:
Long-term functional outcomes and health-related quality of life (HRQoL) in survivors of cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation (ECMO) remain poorly understood.
OBJECTIVES:
This study aimed to evaluate these outcomes in a cohort of venoarterial ECMO survivors.
DESIGN, SETTING, AND PARTICIPANTS:
This single-center observational study was conducted in the ICU of a French academic hospital and included consecutive adult patients treated with venoarterial ECMO who were discharged alive between February 2016 and December 2021.
MAIN OUTCOMES AND MEASURES:
The primary endpoint was a favorable functional outcome at least one year after ICU discharge, defined as a score on the modified Rankin Scale of 0 or 1, indicating no functional limitations affecting usual activities. Secondary endpoints included HRQoL, assessed using the EuroQol 5D five levels (EQ-5D-5L) and 36-item short-form health survey (SF-36) questionnaires. Of 79 hospital survivors, 65 patients were evaluated after a median follow-up of 2.8 years (1.2–4.2 yr). A favorable functional outcome was observed in 35 of 65 patients (54%). No association was found between ICU admission characteristics, serum neurobiomarkers (neuron-specific enolase, S100B), electroencephalogram findings during venoarterial ECMO, and functional outcome. Male sex was the only parameter associated with higher odds of favorable functional outcome (adjusted odds ratio, 4.19; 95% CI, 1.35–14.5). HRQoL assessments showed moderate-to-severe issues in 15% of patients, mainly affecting mobility, pain/discomfort, and mental health. Patients with favorable outcomes reported better scores across all domains of the EQ-5D-5L and higher scores on both the physical and mental components of the SF-36.
CONCLUSIONS AND RELEVANCE:
Approximately half of venoarterial ECMO survivors achieved excellent long-term functional outcomes. Nonetheless, a subset experienced ongoing limitations, particularly related to physical function and mental health, underscoring the need for targeted long-term follow-up and support.
Ovid Technologies (Wolters Kluwer Health)
Title: Long-Term Functional and Quality-of-Life Outcomes in Survivors of Refractory Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation
Description:
IMPORTANCE:
Long-term functional outcomes and health-related quality of life (HRQoL) in survivors of cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation (ECMO) remain poorly understood.
OBJECTIVES:
This study aimed to evaluate these outcomes in a cohort of venoarterial ECMO survivors.
DESIGN, SETTING, AND PARTICIPANTS:
This single-center observational study was conducted in the ICU of a French academic hospital and included consecutive adult patients treated with venoarterial ECMO who were discharged alive between February 2016 and December 2021.
MAIN OUTCOMES AND MEASURES:
The primary endpoint was a favorable functional outcome at least one year after ICU discharge, defined as a score on the modified Rankin Scale of 0 or 1, indicating no functional limitations affecting usual activities.
Secondary endpoints included HRQoL, assessed using the EuroQol 5D five levels (EQ-5D-5L) and 36-item short-form health survey (SF-36) questionnaires.
Of 79 hospital survivors, 65 patients were evaluated after a median follow-up of 2.
8 years (1.
2–4.
2 yr).
A favorable functional outcome was observed in 35 of 65 patients (54%).
No association was found between ICU admission characteristics, serum neurobiomarkers (neuron-specific enolase, S100B), electroencephalogram findings during venoarterial ECMO, and functional outcome.
Male sex was the only parameter associated with higher odds of favorable functional outcome (adjusted odds ratio, 4.
19; 95% CI, 1.
35–14.
5).
HRQoL assessments showed moderate-to-severe issues in 15% of patients, mainly affecting mobility, pain/discomfort, and mental health.
Patients with favorable outcomes reported better scores across all domains of the EQ-5D-5L and higher scores on both the physical and mental components of the SF-36.
CONCLUSIONS AND RELEVANCE:
Approximately half of venoarterial ECMO survivors achieved excellent long-term functional outcomes.
Nonetheless, a subset experienced ongoing limitations, particularly related to physical function and mental health, underscoring the need for targeted long-term follow-up and support.
Related Results
Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality
Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality
Background: Extracorporeal membrane oxygenation is a cardiopulmonary supportive therapy. In this study, we reviewed our experience with extracorporeal membrane oxygenation support ...
Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock
Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock
There are contrasting data on concomitant Impella device in cardiogenic shock patients treated with venoarterial extracorporeal membrane oxygenation (VA ECMO) (ECPELLA). This study...
Refractory Shock. Casuistics
Refractory Shock. Casuistics
Shock Syndrome is an acute progressive circulatory insufficiency where the Heart is unable to circulate the blood in time unit, for supplying with O2 to the cells and to take out f...
Venoarterial Membrane Oxygenation in Cardiogenic Shock Complicated from an Acute Myocardial Infarction: An Overview and Comprehensive Meta-Analysis
Venoarterial Membrane Oxygenation in Cardiogenic Shock Complicated from an Acute Myocardial Infarction: An Overview and Comprehensive Meta-Analysis
Background: Cardiogenic shock remains a significant cause of mortality in patients with acute coronary syndrome, despite early interventions, such as coronary revascularization. Me...
Percutaneous Coronary Intervention for Acute MI Does not Prevent In-Hospital Development of Cardiogenic Shock Compared to Fibrinolysis
Percutaneous Coronary Intervention for Acute MI Does not Prevent In-Hospital Development of Cardiogenic Shock Compared to Fibrinolysis
Abstract
Background
It has been speculated that invasive revascularization prevents development of cardiogenic shock. Dat...
PO-285 A review of effects of exercise on the quality of life in breast cancer survivors
PO-285 A review of effects of exercise on the quality of life in breast cancer survivors
Objective Breast cancer is one of the most common malignant tumors in women.The number of women diagnosed with breast cancer each year is also increasing.It is also the leading cau...
Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation
Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation
AbstractBackgroundCalcium channel blockers and angiotensin II receptor blockers are commonly prescribed to treat hypertension. Massive overdoses can cause both distributive and car...
Pulsatile Right Ventricle to Pulmonary Artery Extracorporeal Membrane Oxygenation in a Pigs
Pulsatile Right Ventricle to Pulmonary Artery Extracorporeal Membrane Oxygenation in a Pigs
Background: We investigated the impact of right ventricle to pulmonary artery extracorporeal membrane oxygenation in acute respiratory dysfunction with or without pulsatile flow. ...

